Protalix BioTherapeutics Inc (PLX)
1.335
+0.08
(+6.80%)
USD |
NYAM |
Nov 04, 13:16
Protalix BioTherapeutics Market Cap: 98.18M for Nov. 4, 2024
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| November 01, 2024 | 91.93M |
| October 31, 2024 | 86.04M |
| October 30, 2024 | 86.04M |
| October 29, 2024 | 86.04M |
| October 28, 2024 | 83.10M |
| October 25, 2024 | 79.43M |
| October 24, 2024 | 75.75M |
| October 23, 2024 | 75.01M |
| October 22, 2024 | 77.96M |
| October 21, 2024 | 77.96M |
| October 18, 2024 | 80.16M |
| October 17, 2024 | 80.16M |
| October 16, 2024 | 80.16M |
| October 15, 2024 | 79.43M |
| October 14, 2024 | 77.96M |
| October 11, 2024 | 79.43M |
| October 10, 2024 | 73.54M |
| October 09, 2024 | 74.28M |
| October 08, 2024 | 75.01M |
| October 07, 2024 | 75.01M |
| October 04, 2024 | 79.43M |
| October 03, 2024 | 74.28M |
| October 02, 2024 | 75.01M |
| October 01, 2024 | 77.22M |
| September 30, 2024 | 75.01M |
| Date | Value |
|---|---|
| September 27, 2024 | 77.22M |
| September 26, 2024 | 78.69M |
| September 25, 2024 | 80.16M |
| September 24, 2024 | 79.43M |
| September 23, 2024 | 82.37M |
| September 20, 2024 | 80.90M |
| September 19, 2024 | 84.57M |
| September 18, 2024 | 80.16M |
| September 17, 2024 | 80.90M |
| September 16, 2024 | 80.16M |
| September 13, 2024 | 77.22M |
| September 12, 2024 | 77.96M |
| September 11, 2024 | 76.48M |
| September 10, 2024 | 75.01M |
| September 09, 2024 | 74.28M |
| September 06, 2024 | 73.54M |
| September 05, 2024 | 75.01M |
| September 04, 2024 | 74.28M |
| September 03, 2024 | 78.69M |
| August 30, 2024 | 69.44M |
| August 29, 2024 | 66.93M |
| August 28, 2024 | 66.19M |
| August 27, 2024 | 67.03M |
| August 26, 2024 | 67.66M |
| August 23, 2024 | 71.17M |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
28.93M
Minimum
Nov 15 2019
282.28M
Maximum
Apr 23 2021
94.51M
Average
86.06M
Median
Jan 12 2023
Market Cap Benchmarks
| Aethlon Medical Inc | 5.642M |
| Predictive Oncology Inc | 4.531M |
| bluebird bio Inc | 91.86M |
| AIM ImmunoTech Inc | 15.86M |
| Armata Pharmaceuticals Inc | 84.67M |
Market Cap Related Metrics
| PS Ratio | 2.778 |
| Price to Book Value | 3.435 |
| Price | 1.335 |
| Earnings Yield | -17.23% |